Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Krystal Biotech Inc (KRYS)
Krystal Biotech Inc (KRYS) News

KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KRYS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
03/09/2023	6:27PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:KRYS	Krystal Biotech Inc
03/06/2023	4:34PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KRYS	Krystal Biotech Inc
03/06/2023	7:00AM	GlobeNewswire Inc.	Krystal Biotech Appoints Catherine Mazzacco to Board of Directors	NASDAQ:KRYS	Krystal Biotech Inc
03/02/2023	7:00AM	GlobeNewswire Inc.	Krystal Biotech to Present at the 43rd Annual TD Cowen Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
02/27/2023	7:26AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KRYS	Krystal Biotech Inc
02/27/2023	7:00AM	GlobeNewswire Inc.	Krystal Biotech Announces Fourth Quarter and Full Year 2022 Financial Results and Operational Progress	NASDAQ:KRYS	Krystal Biotech Inc
02/14/2023	4:45PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KRYS	Krystal Biotech Inc
02/14/2023	4:05PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KRYS	Krystal Biotech Inc
02/14/2023	9:34AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:KRYS	Krystal Biotech Inc
02/09/2023	11:23AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KRYS	Krystal Biotech Inc
02/02/2023	5:02PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:KRYS	Krystal Biotech Inc
01/19/2023	5:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
01/19/2023	5:44PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
01/18/2023	7:00AM	GlobeNewswire Inc.	Krystal Biotech Receives European Commission Orphan Designation for KB407 for the Treatment of Cystic Fibrosis	NASDAQ:KRYS	Krystal Biotech Inc
01/09/2023	8:57AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KRYS	Krystal Biotech Inc
01/09/2023	8:00AM	GlobeNewswire Inc.	Krystal Biotech Announces FDA’s 3-Month Extension of BLA PDUFA Date and Regulatory Update for B-VEC to Treat Patients with Dystrophic Epidermolysis Bullosa	NASDAQ:KRYS	Krystal Biotech Inc
01/05/2023	6:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
01/05/2023	6:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
01/03/2023	6:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
01/03/2023	6:43PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
12/20/2022	5:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc
12/14/2022	5:00PM	GlobeNewswire Inc.	New England Journal of Medicine Publishes Phase 3 Data on B-VEC in Patients with Dystrophic Epidermolysis Bullosa	NASDAQ:KRYS	Krystal Biotech Inc
12/05/2022	7:00AM	GlobeNewswire Inc.	Jeune Aesthetics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference	NASDAQ:KRYS	Krystal Biotech Inc
12/01/2022	7:00AM	GlobeNewswire Inc.	Krystal Biotech to Present at BofA Securities 2022 Biotech SMID Cap Conference	NASDAQ:KRYS	Krystal Biotech Inc
11/23/2022	7:00AM	GlobeNewswire Inc.	Krystal Biotech to Present at 5th Annual Evercore ISI HealthCONx Conference	NASDAQ:KRYS	Krystal Biotech Inc
11/17/2022	4:45PM	TipRanks	Chardan Capital Reaffirms Their Buy Rating on Krystal Biotech (KRYS)	NASDAQ:KRYS	Krystal Biotech Inc
11/17/2022	8:34AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KRYS	Krystal Biotech Inc
11/17/2022	7:00AM	GlobeNewswire Inc.	Jeune Aesthetics Announces Positive Durability Results for KB301 in the PEARL-1 Extension Cohort, an Investigational Gene-based Treatment for Improvement of Fine Lines and Wrinkles	NASDAQ:KRYS	Krystal Biotech Inc
11/10/2022	5:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KRYS	Krystal Biotech Inc

Showing the most relevant articles for your search:NASDAQ:KRYS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Maxeon Solar Technologies

Good Vibrations Shoes (PK)

TPT Global Tech (PK)

Virexit Technologies (PK)

Moon Equity (PK)

Asia Broadband (PK)

Code Green Apparel (PK)

Brookmount Explorations (PK)

Net Savings Link (PK)

Branded Legacy (PK)

Delayed Upgrade Clock